Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong · Delayed Price · Currency is HKD 6.62
+0.30 (4.75%)
Aug 15, 2025, 4:08 PM HKT
HKG:9989 Market Cap
HKG:9989 has a market cap or net worth of 19.45 billion as of August 15, 2025. Its market cap has increased by 39.26% in one year.
Market Cap
19.45B
Enterprise Value
20.04B
Revenue
5.66B
Ranking
n/a
PE Ratio
27.98
Stock Price
6.62
Market Cap Chart
Since May 6, 2010, HKG:9989's market cap has decreased from 79.74B to 19.45B, a decrease of -75.61%. That is a compound annual growth rate of -8.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 19.48B | 29.36% |
| Dec 31, 2024 | 15.06B | -10.92% |
| Dec 29, 2023 | 16.91B | -12.50% |
| Dec 30, 2022 | 19.32B | -30.93% |
| Dec 31, 2021 | 27.97B | -0.50% |
| Dec 31, 2020 | 28.11B | 3.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.60B |
| Hansoh Pharmaceutical Group Company | 223.44B |
| JD Health International | 175.53B |
| Innovent Biologics | 164.42B |
| Akeso | 147.38B |
| Sino Biopharmaceutical | 136.28B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |